Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 560-567 , June 2005

Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives

  • Susan Wieland

      Affiliations

    • Department of Community Health, Center for Gerontology and Health Care Research, Brown University, 2 Stimson Avenue, Providence RI 02912, USA
    • Corresponding Author InformationCorresponding author. Tel.: 401-863-9958; fax: 401-863-3489.
    • Part of this material was previously presented in poster form at the Tenth Cochrane Colloquium, in Stavanger, Norway (Wieland S, Brodney S, Dickersin K. Designing an efficient and precise search strategy for observational studies. 10th Cochrane Colloq Abstr 2002:23–24).
    • ,
  • Kay Dickersin

      Affiliations

    • Center for Clinical Trials and Evidence-Based Healthcare, Brown University Box G-S2, 169 Angell Street, Providence, RI 02912, USA

,Accepted 8 November 2004.

References 

  1. Adams CE, Power A, Frederick K, Lefebvre C. An investigation of the adequacy of Medline searches for randomized controlled trials (RCTs) of the effects of mental health care. Psychol Med. 1994;24:741–748
  2. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286–1291
  3. Hay PJ, Adams CE, Lefebvre C. The efficiency of searches for randomized controlled trials in the International Journal of Eating Disorders: a comparison of handsearching, EMBASE and PsycLIT. Health Libr Rev. 1996;13:91–96
  4. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Int Med. 2001;134:663–694
  5. An evidence based health care system: the case for clinical trials registries. A Technology assessment workshop; Bethesda, MD; Dec. 6–7, 1993. Bethesda, MD: National Institutes of Health, Office of Medical Applications of Research; 1994. Available at: http://consensus.nih.gov/ta/013/013_statement.htm.
  6. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447–458
  7. In:  McKibbon A editors. PDQ evidence-based principles and practice. Hamilton, ON, Canada: B.C. Decker; 1999;
  8. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713–1727
  9. Alexander FE, Roberts MM, Huggins A. Risk factors for breast cancer with applications to selection for the prevalence screen. J Epidemiol Community Health. 1987;41:101–106
  10. Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 1995;87:827–835
  11. Brownson RC, Blackwell CW, Pearson DK, Reynolds RD, Richens JW, Papermaster BW. Risk of breast cancer in relation to cigarette smoking. Arch Intern Med. 1988;148:140–144
  12. Calle EE, Martin LM, Thun MJ, Miracle HL, Heath CW. Family history, age, and risk of fatal breast cancer. Am J Epidemiol. 1993;138:675–681
  13. Clavel F, Andrieu N, Gairard B, Bremond A, Piana L, Lansac J, et al. Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol. 1991;20:32–38
  14. Ewertz M. Oral contraceptives and breast cancer risk in Denmark. Eur J Cancer. 1992;28A:1176–1181
  15. Harris NV, Weiss NS, Francis AM, Polissar L. Breast cancer in relation to pattern of oral contraceptive use. Am J Epidemiol. 1982;116:643–651
  16. Harris RE, Zang EA, Wynder EL. Oral contraceptives and breast cancer risk: a case-control study. Int J Epidemiol. 1990;19:240–246
  17. Hiatt RA, Bawol R, Friedman GD, Hoover R. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer. 1984;54:139–144
  18. Hislop TG, Coldman AJ, Elwood JM, Brauer G, Kan L. Childhood and recent eating patterns and risk of breast cancer. Cancer Detect Prev. 1986;9:47–58
  19. Janerich DT, Polednak AP, Glebatis DM, Lawrence CE. Breast cancer and oral contraceptive use: a case-control study. J Chronic Dis. 1983;36:639–646
  20. Jick SS, Walker AM, Stergachis A, Jick H. Oral contraceptives and breast cancer. Br J Cancer. 1989;59:618–621
  21. Kay CR, Hannaford PC. Breast cancer and the pill: a further report from the Royal College of General Practitioners' Oral Contraception Study. Br J Cancer. 1988;58:675–680
  22. Kelsey JL, Holford TR, White C, Mayer ES, Kilty SE, Acheson RM. Oral contraceptives and breast disease: an epidemiological study. Am J Epidemiol. 1978;107:236–244
  23. La Vecchia C, Negri E, Franceschi S, Talamini R, Amadori D, Filiberti R, et al Oral contraceptives and breast cancer: a cooperative Italian study. Int J Cancer. 1995;60:163–167
  24. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control. 1992;3:313–322
  25. Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whatley AS, Rovira EZ. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst. 1987;79:1247–1254
  26. Marubini E, Decarli A, Costa A, Mazzoleni C, Andreoli C, Barbieri A, et al. The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: results of a case-control study. Cancer. 1988;61:173–180
  27. McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer. 1987;56:653–660
  28. Meirik O, Lund E, Adami HO, Bergstrom R, Christoffersen T, Bergsjo P. Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway. Lancet. 1986;2(8508):650–654
  29. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study I, breast cancer detection and death rates among women aged 40–49 years. CMAJ. 1992;147:1459–1476[Erratum in: CMAJ 1993; 148:718]
  30. Mills PK, Beeson WL, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer. 1989;64:591–597
  31. Morabia A, Szklo M, Stewart W, Schuman L, Thomas DB. Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls. Prev Med. 1993;22:178–186
  32. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med. 1994;330:81–87
  33. Nomura AM, Kolonel LN, Hirohata T, Lee J. The association of replacement estrogens with breast cancer. Int J Cancer. 1986;37:49–53
  34. Olsson H, Moller TR, Ranstam J. Early oral contraceptive use and cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst. 1989;81:1000–1004
  35. Paffenbarger RS, Fasal E, Simmons ME, Kampert JB. Cancer risk as related to use of oral contraceptives during fertile years. Cancer. 1977;39(4 Suppl):1887–1891
  36. Paul C, Skegg DCG, Spears GFS. Oral contraceptives and risk of breast cancer. Int J Cancer. 1990;46:366–373
  37. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983;2(8356):926–930
  38. Primic-Zakelj M, Evstifeeva T, Ravnihar B, Boyle P. Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54. Int J Cancer. 1995;62:414–420
  39. Ravnihar B, Seigel DG, Lindtner J. An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Eur J Cancer. 1979;15:395–405
  40. Ravnihar B, Primic-Zakelj M, Kosmelj K, Stare J. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma. 1988;35:109–121
  41. Rohan TE, McMichael AJ. Oral contraceptive agents and breast cancer: a population-based case-control study. Med J Aust. 1988;149:520–526
  42. Romieu I, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, et al. Prospective study of oral contraceptive use and the risk of breast cancer in women. J Natl Cancer Inst. 1989;81:1313–1321
  43. Rookus MA, van Leeuwen FE, Netherlands Oral Contraceptives and Breast Cancer Study Group . Oral contraceptives and risk of breast cancer in women aged 20–54 years. Lancet. 1994;344:844–851
  44. Rosenberg L, Palmer JR, Clarke EA, Shapiro S. A case-control study of the risk of breast cancer in relation to oral contraceptive use. Am J Epidemiol. 1992;136:1437–1444
  45. Ross RK, Paganini-Hill A, Gerkins VR, Mack TM, Pfeffer R, Arthur M, et al. A case-control study of menopausal estrogen therapy and breast cancer. JAMA. 1980;243:1635–1639
  46. Sartwell PE, Arthes FG, Tonascia JA. Exogenous hormones, reproductive history, and breast cancer. J Natl Cancer Inst. 1977;59:1589–1592
  47. Schildkraut JM, Hulka BS, Wilkinson WE. Oral contraceptives and breast cancer: a case-control study with hospital and community controls. Obstet Gynecol. 1990;76:395–402
  48. Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study. Cancer Causes Control. 1995;6:416–424
  49. Segala C, Gerber M, Richardson S. The pattern of risk factors for breast cancer in a Southern France population: interest for a stratified analysis by age at diagnosis. Br J Cancer. 1991;64:919–925
  50. Siskind V, Schofield F, Rice D, Bain C. Breast cancer and breastfeeding: results from an Australian case-control study. Am J Epidemiol. 1989;130:229–236
  51. Stanford JL, Brinton LA, Hoover RN. Oral contraceptives and breast cancer: results from an expanded case-control study. Br J Cancer. 1989;60:375–381
  52. Talamini R, La Vecchia C, Franceschi S, Colombo F, Decarli A, Grattoni E, et al. Reproductive and hormonal factors and breast cancer in a Northern Italian population. Int J Epidemiol. 1985;14:70–74
  53. Tavani A, Negri E, Franceschi S, Parazzini F, La Vecchia C. Oral contraceptives and breast cancer in northern Italy: final report from a case-control study. Br J Cancer. 1993;68:568–571
  54. UK National Case-Control Study Group . Oral contraceptive use and breast cancer risk in young women. Lancet. 1989;1(8645):973–982
  55. Ursin G, Aragaki CC, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Oral contraceptives and premenopausal bilateral breast cancer: a case-control study. Epidemiology. 1992;3:414–419
  56. Vessey M, Baron J, Doll R, McPherson K, Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983;47:455–462
  57. Vessey MP, McPherson K, Villard-Mackintosh L, Yeates D. Oral contraceptives and breast cancer: latest findings in a large cohort study. Br J Cancer. 1989;59:613–617
  58. Wang DY, de Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, et al. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Clin Oncol. 1987;23:1541–1548
  59. Wang Q-S, Ross RK, Yu MC, Ning J-P, Henderson BE, Kimm HT. A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev. 1992;1:435–439
  60. Weinstein AL, Mahoney MC, Nasca PC, Leske MC, Varma AO. Breast cancer risk and oral contraceptive use: results from a large case-control study. Epidemiology. 1991;2:353–358
  61. White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst. 1994;86:505–514
  62. WHO Collaborative Study of Neoplasia and Steroid Contraceptives . Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer. 1990;61:110–119
  63. Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol. 1991;78:161–170
  64. Wynder EL, MacCornack FA, Stellman SD. The epidemiology of breast cancer in 785 United States Caucasian women. Cancer. 1978;41:2341–2354
  65. Yang CP, Daling JR, Band PR, Gallagher RP, White E, Weiss NS. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control. 1992;3:475–479
  66. Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res. 1988;48:1949–1953
  67. Indexing operation. Chapter 4. In: Indexing Manual [Internet]. Bethesda, MD: National Library of Medicine. Available at: http://www.nlm.nih.gov/mesh/indman/chapter_4.html (accessed June 29, 2004).
  68. Watson RJD, Richardson PH. Accessing the literature on outcome studies in group psychotherapy: the sensitivity and precision of Medline and PsycINFO bibliographic database searching. Br J Med Psychol. 1999;72:127–134
  69. Derry S, Loke YK, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol. 2001;1(1):7
  70. Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med. 2000;19:3325–3336
  71. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat. 2000;49:359–370
  72. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized controlled trials: comparison of protocols to published articles. JAMA. 2004;291:2457–2465
  73. McPherson K, Hemminki E. Synthesising licensing data to assess drug safety. BMJ. 2004;328:518–520
  74. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012
  75. Des Jarlais DC, Lyles C, Crepaz N, TREND Group . Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94:361–366
  76. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol. 2002;31:150–153
  77. Dickersin K, Manheimer E, Wieland S, Robinson KA, Lefebvre C, McDonald S. Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials. Eval Health Prof. 2002;25:38–64
  78. Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials: a systematic survey. BMC Clin Pharmacol. 2001;1(1):3

PII: S0895-4356(04)00329-4

doi: 10.1016/j.jclinepi.2004.11.018

Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 560-567 , June 2005

Article Tools